InvestorsHub Logo
Followers 19
Posts 932
Boards Moderated 0
Alias Born 06/29/2020

Re: BBalls-N-CowTown post# 148816

Thursday, 02/25/2021 11:06:03 PM

Thursday, February 25, 2021 11:06:03 PM

Post# of 232085
Add the OLE patients who are chosen according to the same criteria as the trial participants, but instead of 2:1, they all get leronlimab. Compare them to the folks in the hospital who do NOT want to try lernonlimab. Now you have your extension of more patients and follow them for the 14, 28, new 42 and 60 day. And maybe start getting the data from the trial sites to see if they can follow up on trial participants. It can be done IF FDA approves. That is what I would be discussing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News